Literature DB >> 20967825

Positron emission tomography scan for a hepatic mass.

Boris Blechacz1, Gregory J Gores.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20967825      PMCID： PMC3059121          DOI： 10.1002/hep.24002

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  28 in total

1.  Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma.

Authors:  Satoru Seo; Etsuro Hatano; Tatsuya Higashi; Tadashi Hara; Masaharu Tada; Nobuyuki Tamaki; Keiko Iwaisako; Iwao Ikai; Shinji Uemoto
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

2.  Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.

Authors:  Yen-Kung Chen; Dar-Shih Hsieh; Chao-Sheng Liao; Chyi-Huey Bai; Chen-Tau Su; Yeh-You Shen; Jih-Fang Hsieh; Alfred C Liao; Chia-Hung Kao
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

3.  Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.

Authors:  S Keiding; S B Hansen; H H Rasmussen; A Gee; A Kruse; K Roelsgaard; U Tage-Jensen; J F Dahlerup
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

4.  A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET.

Authors:  Ai Oe; Daiki Habu; Joji Kawabe; Kenji Torii; Etsushi Kawamura; Jin Kotani; Takehiro Hayashi; Hiroki Sakaguchi; Susumu Shiomi
Journal:  Ann Nucl Med       Date:  2005-09       Impact factor: 2.668

5.  Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.

Authors:  Henrik Petrowsky; Peer Wildbrett; Daniela B Husarik; Thomas F Hany; Simona Tam; Wolfram Jochum; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2006-04-19       Impact factor: 25.083

6.  Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.

Authors:  Hanne Prytz; Susanne Keiding; Einar Björnsson; Ulrika Broomé; Sven Almer; Maria Castedal; Ole Lajord Munk
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

Review 7.  The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.

Authors:  Bastiaan Wiering; Paul F M Krabbe; Gerrit J Jager; Wim J G Oyen; Theo J M Ruers
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

8.  Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma.

Authors:  Wan-Yu Lin; Shih-Chuan Tsai; Guang-Uei Hung
Journal:  Nucl Med Commun       Date:  2005-04       Impact factor: 1.690

9.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.

Authors:  Christopher D Anderson; Michael H Rice; C Wright Pinson; William C Chapman; Ravi S Chari; Dominique Delbeke
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

10.  18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.

Authors:  Masahiro Sugiyama; Harumi Sakahara; Tatsuo Torizuka; Toshihiko Kanno; Fumitoshi Nakamura; Masami Futatsubashi; Satoshi Nakamura
Journal:  J Gastroenterol       Date:  2004-10       Impact factor: 7.527
View more
  5 in total

Review 1.  Clinical diagnosis and staging of cholangiocarcinoma.

Authors:  Boris Blechacz; Mina Komuta; Tania Roskams; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-02       Impact factor: 46.802

2.  Diffuse Large B-Cell Lymphoma in the Portal Vein.

Authors:  Hyun Ji Lim; Mi-Suk Park; Yeo-Eun Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-04-23

3.  Distal extrahepatic cholangiocarcinoma mimicking groove pancreatitis: A case report and literature review.

Authors:  Chaoqun Han; Xin Ling; Liping Sheng; Ming Yang; Rong Lin; Zhen Ding
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

4.  Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.

Authors:  Hyun Gyu Lee; Hyemi Kim; Taekwon Son; Youngtae Jeong; Seung Up Kim; Seung Myung Dong; Young Nyun Park; Jong Doo Lee; Jae Myun Lee; Jeon Han Park
Journal:  Oncotarget       Date:  2016-07-05

Review 5.  Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Onur Yaprak; Sencan Acar; Gokhan Ertugrul; Murat Dayangac
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.